Qube Research & Technologies LTD I Bio, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $4,095 - $2.85 Million	-17,807 Reduced 9.96%	160,989 $27,000
Q2 2022 Aug 15, 2022	BUY	$0.23 - $0.46 $41,123 - $82,246	178,796 New	178,796 $47,000
Q1 2022 May 09, 2022	SELL	$0.3 - $0.61 $65,314 - $132,806	-217,716 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$0.55 - $1.04 $119,743 - $226,424	217,716 New	217,716 $120,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.